Company Information
As of 6/5/23
Country
U.S.
Headquarters
Canonsburg, Pa.
Industry
Pharmaceuticals
CEO
Scott A. Smith
Website
Company Type
Public
Ticker
VTRS
Revenues ($M)
$16,263
Profits ($M)
$2,079
Market Value ($M)
$11,513
Employees
37,000
Market value as of March 31, 2023.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$16,262.7
-9.1%
Profits ($M)
$2,078.6
-
Assets ($M)
$50,022.2
-
Total Stockholder Equity ($M)
$21,072.3
-
Profit Ratios
Profit as % of Revenues
12.8%
Profits as % of Assets
4.2%
Profits as % of Stockholder Equity
9.9%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
1.71
EPS % Change (from 2021)
-
EPS % Change (5 year annual rate)
-
EPS % Change (10 year annual rate)
-
Total Return
Total Return to Investors (2022)
-13.8%
Total Return to Investors (5 year, annualized)
-
Total Return to Investors (10 year, annualized)
-
Viatris Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2022 | $17,88649.7% | $-1,269 | $54,843 | $20,493 |
| 2021 | $11,946 | $-670 | $61,553 | $22,954 |
| 2020 |
Lists ranking Viatris
